Another Inquiry Into Psychiatry’s Drugs Prescribed for Invented Disorders

Research, conducted by the Citizens Commission on Human Rights a psychiatric watchdog group established by the Church of Scientology, showed that in only the past two years 18 government warnings by five different countries including Switzerland, England, Canada, the US and Europe have been issued on the previously undisclosed dangers of psychiatric drugs citing side effects of drug dependence, addiction, mania, hostility, aggression, psychosis, suicide and violence.

The latest issue against psychiatry’s drugs came from Health Canada, recently, which warned of heart risks for all drugs used for the made-up “disease” known as Attention Deficit Hyperactivity Disorder. The warnings include a risk of sudden death. The mind altering drugs are the most widely prescribed drugs to Canadian children and, according to a public advisory, can increase heart rate and blood pressure.

Brian Beaumont, President of the Vancouver chapter of the Citizens Commission on Human Rights stated, “The fact is, there is nothing in any medical or scientific literature that confirms the existence of Attention-Deficit/Hyperactivity Disorder (ADHD). It was invented by a handful of psychiatrists by a show of hands at an American Psychiatric Association meeting in the 80’s. Thus, psychiatrists are labeling and drugging a non-existent malady which is an indictable offence, fraud and child abuse.”

The health agency has made the safety labels and prescribing information stronger on the psychiatric drugs: Adderall XR, Concerta, Dexedrine, Ritalin and Ritalin SR and Strattera, as well as Attenade and Biphentin, two drugs that are not yet available in Canada.

More than 1.9 million prescriptions for the stimulants were filled by Canadian retail drugstores in the 12 months ending April 30, 2006, according to health research firm IMS Health. An estimated three million U.S. children and 1.5 million adults are on psycho-stimulants.

One prevailing psychiatric theory (key to psychotropic drug and amphetamine type drug sales) is that mental disorders result from a chemical imbalance in the brain. As with this and psychiatry’s other theories, there is no biological or other evidence to prove them. Representative of a large group of medical and biochemistry experts, Elliot Valenstein, Ph.D., author of Blaming the Brain says: “There are no tests available for assessing the chemical status of a living person’s brain.”

There have been 25 reports in the U.S. of children and adults who died suddenly between 1999 and 2003 after taking one of the drugs, including a 13-year-old boy who died within one hour of receiving his first dose. An autopsy revealed he had a heart disorder.

The Citizens Commission on Human Rights was established in 1969 by the Church of Scientology to investigate and expose psychiatric violations of human rights. For more information and a complete list of recent government inquiries go to http://www. cchr.org.

New User-friendly of Evidence-based Integrated Dual Disorders Treatment (IDDT) and Companion Materials Now Available from Hazelden

New User-friendly of Evidence-based Integrated Dual Disorders Treatment (IDDT) and Companion Materials Now Available from Hazelden










Center City, MN (PRWEB) August 23, 2011

As many as half of all people who arrive at mental health clinics or addiction treatment facilities have co-occurring disorders, requiring effective, integrated care as outlined in IDDT. Recognizing the need for comprehensive research and information about dual diagnosis and IDDT treatment in a format that guides professionals in implemented integrated treatment practices, the Dartmouth Psychiatric Research Center and Hazelden have redesigned the acclaimed Integrated Dual Disorders Treatment (IDDT) and Hazelden is now offering the program, one component of the larger Severe Mental Illness (SMI) product line– on its website.

Far surpassing its predecessor in ease of implementation and ongoing usability in clinical settings, this updated and expanded IDDT curriculum is redesigned not only to more effectively teach clinical skills and provide practitioners with resources and tools for their practice, but to offer the guidance necessary to align the work of departments and transform agencies into integrated treatment providers.

Identified as an evidence-based practice (EBP) by the Substance Abuse Mental Health Services Administration, IDDT calls for mental health and substance abuse treatment to be delivered at the same place, at the same time, and with the same treatment team. As funding for behavioral health treatment becomes scarce, only the most clinically- and cost-effective interventions and evidence-based practices will pass muster with mental-health authorities and policy makers. But while EBPs have been shown to produce better clinical outcomes, they are also perceived to be more expensive services.

A groundbreaking study of behavior healthcare claims data in Ohio found just the opposite was true – Integrated Dual Disorders Treatment actually helped save $ 1.4 million in service costs for a group of 160 people with severe mental illness and co-occurring substance abuse disorders.

Hazelden and the Dartmouth Psychiatric Research Center (PRC) have also created a Recovery Life Skills Program that is designed to work hand in hand with the new and improved IDDT program.

Developed by Lindy Fox, MA, LADC of the PRC, the Recovery Life Skills Program also utilizes evidence-based protocols. The Program has been research tested at eight pilot sites by Dartmouth researchers, and the easy-to-implement curriculum includes a facilitator’s guide with step-by-step session instructions and reproducible client handouts–everything needed for rapid integration, and to revise existing programs into those found in dual diagnosis treatment centers.

Hazelden offers a comprehensive collection of professional resources for the integrated treatment of co-occurring disorders, including the evidence-based Co-occurring Disorders Program (CDP) and the SMI product line In addition to the IDDT and Recovery Life Skills materials, Hazelden’s SMI line includes Housing First Collection advocates providing housing first, then supportive treatment services. The program materials offer guidance, tools and tips to evolve existing programs into the Housing First model, and for implementation within the community.

Rounding out Hazelden’s educational offerings for addiction and mental health practitioners is Supported Employment, Individual Placement and Support (IPS), training materials and curricula to help clients compete in the workforce. Studies have shown that participants in an Individual Placement and Support (IPS) program are three times more likely to work in regular, competitive jobs than those in other vocational programs. The evidence-based practices in Supported Employment offers knowledge and tools born from the IPS model to help clients with mental health disorders obtain jobs with competitive wages based on their field of interest.

Hazelden is a private, not-for-profit organization, Hazelden helps people transform their lives by providing the best addiction treatment and recovery services as well as education, research, and publishing products available today.

###





















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Post-Hurricane Efforts Raise Profile of Mental Disorders

Post-Hurricane Efforts Raise Profile of Mental Disorders











Mental Illness Awareness Week poster


Belleville, IL (Vocus) September 25, 2008

It is the storm damage that people often don’t talk about–mental disorders such as depression, anxiety and post-traumatic stress disorder that strike in the wake of a catastrophic experience.

Post-trauma mental conditions are one of many mental disorders that affect some 57.7 million Americans in any given year, according to the National Alliance on Mental Illness, which is observing Mental Illness Awareness Week, Oct. 5-11, 2008. Organizations, including Allsup, which represents people nationwide for Social Security Disability Insurance benefits, are helping to raise awareness about mental illnesses and the help available to people and their families.

Anxiety disorders, including post-traumatic stress disorder (PTSD), panic disorder and phobias, affect about 40 million people, NAMI reports. One in five veterans of Iraq and Afghanistan (almost 300,000 troops) will experience major depression or PTSD when they return home. Other types of mental disorders also affect millions of people, including 5.7 million with bipolar disorder and 2.4 million who have schizophrenia.

“People living with mental illnesses often are among the most vulnerable in our society. Unfortunately, they also are often overlooked during disasters,” said NAMI executive director Michael J. Fitzpatrick, who recently announced the creation of a NAMI Hurricane Relief Fund to help individuals and families affected by hurricanes Gustav and Ike.

NAMI makes a number of resources and support available through its Web site, including:

    About Medications: Find details on specific medications, dosages and treatment information.
    State & Local NAMIs: Get contact information for local associations through a state-by-state guide.
    Support Programs: Find support and build connections through peer-to-peer, family and caregiver offerings.

One of the most significant facts about mental illness is that two-thirds of people living with a condition do not receive treatment. During Mental Illness Awareness Week, the association is emphasizing the theme, “Building Community. Taking Action.”

Mental illness can affect anyone at any time, and the benefit for individuals and their families comes from realizing that mental health is a part of everyone’s well-being and healthcare.

Allsup is observing Mental Illness Awareness Week with free posters available to hospitals, clinics and other community groups by calling Karen Hercules-Doerr at (800) 854-1418, ext. 5770.

Media contact:

National Alliance on Mental Illness

Christine Armstrong

(703) 524-7600

christinea@nami.org

http://www.nami.org

Free posters:

Allsup

Karen Hercules-Doerr

(800) 854-1418, ext. 5770

k.hercules-doerr@allsupinc.com

http://www.allsupcares.com

###






















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Psychiatry?s Claims of Childhood Disorders False And Unsubstantiated

Psychiatry’s Claims of Childhood Disorders False And Unsubstantiated










(PRWEB) October 9, 2005

Members of the Vancouver chapter of the Citizens Commission on Human Rights are challenging psychiatry’s statement that 140,000 British Columbia children have some sort of “mental disorder” by calling it fraudulent, an attempt to cash in at the expense of vulnerable and helpless little children and an effort to seduce well meaning teachers, parents, government officials and others into believing their trumped-up “disorders” actually exist.

Psychiatric leaders themselves admit that they do not know how the mind works or how to help with mental difficulties. Past president of the World Psychiatric Association stated, “The time when psychiatrists considered that they could cure the mentally ill is gone. In the future, the mentally ill have to learn to live with their illness.

Since last October, official warnings of the side effects of psychiatric drugs by regulatory agencies worldwide have escalated rapidly – sixteen in the last twelve months alone – culminating in a September 2005 landmark report by the United Nations Committee on the Rights of the Child, which issued a strong warning against false labeling of youth with the psychiatric diagnosis of “Attention Deficit Hyperactivity Disorder” (ADHD) and its treatment with powerful mind-altering psychiatric drugs.

CCHR has published a new White Paper, summarizing the past year’s official warnings and providing recommendations to protect the public health from further harm. It can be viewed at their website.

Psychiatry’s drugs of choice for Attention Deficit Disorder ( ADHD), one of their invented “illnesses”, came under fire last month when Health Canada asked all the makers of drugs used for ADHD to submit data from all clinical trials and post-marketing reports by the end of 2005. The data will be examined following it’s submission in the new year. The drugs that will be reviewed are Concerta, Adderall XR, Dexadrine, Ritalin and Attenade; drugs which are given to children for ADHD.

The psychiatric amphetamine type drug Adderall which was banned from the Canadian market in February 2005 and then allowed back on the market in August, is now to be reviewed again according to a spokesperson for Health Canada.

On September 29, the U.S. Food and Drug Administration ordered that “black box” warnings be placed on a commonly prescribed ADHD drug, Strattera, after clinical trials linked the drug to suicidal thoughts and behavior. The FDA indicated that the new warning stems from an ongoing review of all ADHD drugs and their possible association with suicide.

Brian Beaumont, President of the Vancouver chapter of the Citizens Commission on Human Rights stated, “The fact is, there is nothing in any medical or scientific literature that confirms the existence of Attention-Deficit/Hyperactivity Disorder (ADHD). It was invented by a handful of psychiatrists by a show of hands at an American Psychiatric Association meeting in the 80’s. Thus, psychiatrists are labeling and drugging a non-existent malady which is an indictable offence, fraud and child abuse.”

The Citizens Commission on Human Rights was established in 1969 by the Church of Scientology to investigate and expose psychiatric violations of human rights. For more information go to http://www.cchr.org

If you or a loved one has been harmed by any psychiatric practice, please call the Citizens Commission on Human Rights at 1-800-670-2247.

###



















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.